Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UK Childhood Cancer Survival Falling Behind The Rest Of Europe

01.08.2007
Children with cancer in the UK have shorter survival than their counterparts in other European countries. This disparity needs to be addressed urgently, according to The Keynote Comment in the August issue of The Lancet Oncology.

Despite a National Service Framework for children, which sets standards, there are no targets, and children continue to be a low priority for the NHS.

According to Alan Craft (Institute of Child Health, Newcastle Upon Tyne, UK) and Kathy Pritchard-Jones (Royal Marsden Hospital and Institute of Cancer Research, Surrey, UK), routine surveillance and the primary care of children need to be rigorously assessed, while politicians need to take the health of children seriously and make an appropriate level of investment, to ensure that the UK improves by comparison with the best-performing countries in Europe.

The authors highlight that in Germany, trials on Wilm’s tumour—a common solid tumour of childhood— showed that between 1994 and 2001, 27.4% of patients had a cancer that was first identified during a visit to a health professional for an unrelated problem or by routine surveillance. In comparison, in the UK, just 11% of patients presenting to the Royal Marsden Hospital in London, and 4% of patients referred to the Newcastle Hospital or the Royal Victoria Infirmary in Newcastle were identified. In Germany, early diagnosis by routine or incidental examination was linked to increased survival.

The authors suggest a number of possible reasons for the considerable variation in childhood cancer survival in the UK. They believe that children in the UK have been receiving a different treatment protocol than their European counterparts possibly involving suboptimum first-line treatment or less-intensive salvage treatment at relapse, because until recently there was no European-wide standard clinical protocol. Furthermore, routine health-surveillance systems and opportunities for diagnosis for children differ considerably across Europe. In Germany, most children have their own primary-care paediatrician who undertakes regular health checks, whereas in the UK, according to the authors, the Health for all Children guidelines are not as thorough, with few routine examinations being recommended.

The authors conclude, “Suboptimum survival for childhood cancer is just one example of the worse state of children’s health care in the UK compared with many other countries. The perinatal mortality rate puts the UK in 15th position in Europe and there is clear evidence that children with diabetes are [also] not receiving optimum care”.

Tony Kirby | alfa
Further information:
http://www.thelancet.com

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Flying: Efficiency thanks to Lightweight Air Nozzles

23.10.2017 | Materials Sciences

Salmonella as a tumour medication

23.10.2017 | Life Sciences

50th Anniversary at JULABO GmbH

23.10.2017 | Press release

VideoLinks
B2B-VideoLinks
More VideoLinks >>>